Skip to main content

ADVERTISEMENT

Frank J. Criado, MD

Commentary
07/31/2013
EVAR continues to evolve, and moving forward the appeal of percutaneous EVAR, with availability of lower profile and highly flexible systems and the expanding capability to achieve successful endovascular repair of juxtarenal and pararenal...
EVAR continues to evolve, and moving forward the appeal of percutaneous EVAR, with availability of lower profile and highly flexible systems and the expanding capability to achieve successful endovascular repair of juxtarenal and pararenal...
EVAR continues to evolve, and...
07/31/2013
Vascular Disease Management
Review
07/05/2016
Kommerell’s aortic diverticula are infrequent but perhaps not as rare as previously estimated. This article illustrates measurement techniques for these lesions to assist interventionalists in developing treatment plans, including hybrid...
Kommerell’s aortic diverticula are infrequent but perhaps not as rare as previously estimated. This article illustrates measurement techniques for these lesions to assist interventionalists in developing treatment plans, including hybrid...
Kommerell’s aortic diverticula...
07/05/2016
Vascular Disease Management
Editor's Corner
09/05/2008
It was the December issue 2004 of VDM when we last editorialized about the status of carotid artery stenting (CAS) in these pages. And quite a bit has happened since! Taking into account the continuing strength and impact of carotid...
It was the December issue 2004 of VDM when we last editorialized about the status of carotid artery stenting (CAS) in these pages. And quite a bit has happened since! Taking into account the continuing strength and impact of carotid...
It was the December issue 2004...
09/05/2008
Vascular Disease Management
Editor's Corner
09/05/2008
“And I said of medicine, that this is an art which considers the constitution of the patient, and has principles of actions and reasons in each case.” – Plato: Georgias.
“And I said of medicine, that this is an art which considers the constitution of the patient, and has principles of actions and reasons in each case.” – Plato: Georgias.
“And I said of medicine, that...
09/05/2008
Vascular Disease Management
Editor's Corner
09/05/2008
I must say it was heartening to hear the many nice comments on my last Editor’s Corner in the September/October issue. And while wanting to believe such reactions were prompted by my sharp pen and lofty writing… I know better than that!...
I must say it was heartening to hear the many nice comments on my last Editor’s Corner in the September/October issue. And while wanting to believe such reactions were prompted by my sharp pen and lofty writing… I know better than that!...
I must say it was heartening to...
09/05/2008
Vascular Disease Management
Commentary
11/04/2013
This update summarizes the thoracic endovascular landscape, including currently approved devices in the United States and other countries, on-label indications, and trends in use of TEVAR devices.   
This update summarizes the thoracic endovascular landscape, including currently approved devices in the United States and other countries, on-label indications, and trends in use of TEVAR devices.   
This update summarizes the...
11/04/2013
Vascular Disease Management
Interview
09/05/2008
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI...
09/05/2008
Vascular Disease Management
Editor's Corner
09/05/2008
At the dawn of a new year, it should come as no surprise that yet a further update on the status of carotid stenting (CAS) is warranted. Developments of the past several months appear to have triggered (or quickened the pace of) changes in...
At the dawn of a new year, it should come as no surprise that yet a further update on the status of carotid stenting (CAS) is warranted. Developments of the past several months appear to have triggered (or quickened the pace of) changes in...
At the dawn of a new year, it...
09/05/2008
Vascular Disease Management
Clinical Editor's Corner
11/04/2013
The US Food and Drug Administration approval of Gore’s Conformable GORE TAG Thoracic Endoprosthesis for endovascular repair of acute and chronic type B dissections of the descending thoracic aorta will enable physicians to exchange...
The US Food and Drug Administration approval of Gore’s Conformable GORE TAG Thoracic Endoprosthesis for endovascular repair of acute and chronic type B dissections of the descending thoracic aorta will enable physicians to exchange...
The US Food and Drug...
11/04/2013
Vascular Disease Management
Editor's Corner
09/05/2008
Diseases of the thoracic aorta are relatively frequent and often life-threatening. Degenerative thoracic aneurysms (TAA) and aortic dissection (AD) are the most common and best-known, but a number of other significant lesions are also...
Diseases of the thoracic aorta are relatively frequent and often life-threatening. Degenerative thoracic aneurysms (TAA) and aortic dissection (AD) are the most common and best-known, but a number of other significant lesions are also...
Diseases of the thoracic aorta...
09/05/2008
Vascular Disease Management